Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 9.85 M12.19 M9.65 M10.54 M9.57 M 41.94 M Research & development 1.11 M1.03 M995.77 K927.8 K1.04 M 3.99 M Operating income 3.23 M3.14 M1.72 M2.58 M1.32 M 8.77 M Non-Operating Income, Total -199.71 K75.21 K-157.64 K-217.12 K13.19 K -286.37 K Interest expense, net of interest capitalized 617.47 K636.29 K688.42 K742.42 K527.51 K 2.59 M Non-Operating Income, excl. Interest Expenses -617.47 K-636.29 K-688.42 K-742.42 K-527.51 K -2.59 M Unusual income/expense -199.71 K75.21 K-157.64 K-217.12 K13.19 K -286.37 K Pretax income 2.41 M2.58 M876.65 K1.62 M810.39 K 5.89 M Equity in earnings ————— — Taxes 507.18 K546.38 K297.71 K171.07 K170.26 K 1.19 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 1.91 M2.03 M578.94 K1.17 M640.13 K 4.42 M Discontinued operations 36.88 K1.41 M056.08 K0 1.46 M Net income 1.94 M3.44 M578.94 K1.17 M640.13 K 5.83 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.94 M3.44 M578.94 K1.17 M640.13 K 5.83 M Basic earnings per share (Basic EPS) 0.320.560.10.190.11 0.96 Diluted earnings per share (Diluted EPS) 0.320.560.10.190.11 0.96 Average basic shares outstanding 6.14 M6.11 M6.08 M6.09 M6.04 M — Diluted shares outstanding 6.15 M6.12 M6.08 M6.1 M6.05 M — EBITDA ————— — EBIT 1.71 M1.44 M-86.42 K758.85 K-360.88 K 1.75 M Cost of revenue 49.13 M53.8 M42.97 M46.11 M47.75 M 190.63 M Other cost of goods sold 36.54 M40.56 M40.56 M—33.13 M — Depreciation & amortization (cash flow) ————— —